Solution

THE POSSIBILITIES ARE ENDLESS Pharmaceutical companies are continuously looking for ways to innovate – through new technologies such as controlled...

Addressing poor solubility and permeability issues associated with synthetic drugs and naturally occurring active compounds is crucial for improving bioavailability....

See the new book, edited by R. Rajakumari and Sabu Thomas. Overview: Cutting-edge interdisciplinary book focused on the nutraceuticals and nano nutraceuticals...

Caring for patients Patient preferences and needs as well as therapeutic indication should be considered at early stage of development...

PRESS RELEASE 10 August 2023 Croda Pharma has introduced a critical range of new bioprocessing detergents optimised for viral inactivation...

Abstract Pulmonary delivery of mRNA via inhalation is a very attractive approach for RNA-based therapy for treatment of lung diseases....

Active pharmaceutical ingredients (APIs) can exist in multiple crystal forms, known as polymorphs, that are chemically identical. Polymorphs of an...

ABSTRACT Background: As the pharmaceutical industry shifts to a patient-oriented approach, pharmaceutical education has fairly garnered increasing attention from educators,...

Don’t let poor solubility affect your innovative drug projects Approximately 60% of potential active pharmaceutical ingredients (APIs) under development, and...

Pazopanib is the first-line treatment for patients with advanced or metastatic renal cell carcinoma. However, the commercially available preparation is...